Addus HomeCare (NASDAQ:ADUS) Receives “Outperform” Rating from Royal Bank of Canada

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “outperform” rating reiterated by Royal Bank of Canada in a note issued to investors on Thursday,Benzinga reports. They presently have a $136.00 price target on the stock. Royal Bank of Canada’s price target points to a potential upside of 10.90% from the company’s current price.

ADUS has been the subject of a number of other research reports. TD Cowen increased their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Oppenheimer raised their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stephens lifted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Down 0.5 %

Shares of Addus HomeCare stock traded down $0.66 on Thursday, hitting $122.63. The stock had a trading volume of 12,337 shares, compared to its average volume of 131,230. The stock has a market cap of $2.22 billion, a price-to-earnings ratio of 28.06, a PEG ratio of 2.20 and a beta of 1.04. Addus HomeCare has a one year low of $85.43 and a one year high of $136.12. The stock’s 50-day simple moving average is $129.27 and its two-hundred day simple moving average is $122.06.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 earnings per share. As a group, equities analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 over the last quarter. 4.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds have recently added to or reduced their stakes in ADUS. Vanguard Group Inc. grew its position in shares of Addus HomeCare by 1.5% during the first quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after buying an additional 19,027 shares in the last quarter. Point72 Asset Management L.P. lifted its position in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after purchasing an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares in the last quarter. Principal Financial Group Inc. raised its stake in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. Finally, WCM Investment Management LLC lifted its holdings in Addus HomeCare by 2.9% during the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock worth $65,250,000 after buying an additional 13,938 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.